These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial. Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961 [TBL] [Abstract][Full Text] [Related]
23. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. Firth J; Teasdale SB; Allott K; Siskind D; Marx W; Cotter J; Veronese N; Schuch F; Smith L; Solmi M; Carvalho AF; Vancampfort D; Berk M; Stubbs B; Sarris J World Psychiatry; 2019 Oct; 18(3):308-324. PubMed ID: 31496103 [TBL] [Abstract][Full Text] [Related]
24. The role of omega-3 fatty acids in mood disorders. Stahl LA; Begg DP; Weisinger RS; Sinclair AJ Curr Opin Investig Drugs; 2008 Jan; 9(1):57-64. PubMed ID: 18183532 [TBL] [Abstract][Full Text] [Related]
25. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Keck PE; Mintz J; McElroy SL; Freeman MP; Suppes T; Frye MA; Altshuler LL; Kupka R; Nolen WA; Leverich GS; Denicoff KD; Grunze H; Duan N; Post RM Biol Psychiatry; 2006 Nov; 60(9):1020-2. PubMed ID: 16814257 [TBL] [Abstract][Full Text] [Related]
26. Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial. Sarris J; Byrne GJ; Stough C; Bousman C; Mischoulon D; Murphy J; Macdonald P; Adams L; Nazareth S; Oliver G; Cribb L; Savage K; Menon R; Chamoli S; Berk M; Ng CH J Affect Disord; 2019 Feb; 245():1007-1015. PubMed ID: 30699842 [TBL] [Abstract][Full Text] [Related]
27. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study. Hobbs T; Caso R; McMahon D; Nymark M Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367 [TBL] [Abstract][Full Text] [Related]
28. Vitamin D and N-Acetyl Cysteine Supplementation in Treatment-Resistant Depressive Disorder Patients: A General Review. di Michele F; Talamo A; Niolu C; Siracusano A Curr Pharm Des; 2020; 26(21):2442-2459. PubMed ID: 32250212 [TBL] [Abstract][Full Text] [Related]
29. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Sarris J; Mischoulon D; Schweitzer I J Clin Psychiatry; 2012 Jan; 73(1):81-6. PubMed ID: 21903025 [TBL] [Abstract][Full Text] [Related]
30. A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder. Ashton MM; Kavanagh BE; Marx W; Berk M; Sarris J; Ng CH; Hopwood M; Williams LJ; Dean OM Can J Psychiatry; 2021 Mar; 66(3):262-273. PubMed ID: 32966097 [TBL] [Abstract][Full Text] [Related]
31. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements. Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527 [TBL] [Abstract][Full Text] [Related]
32. Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression. Bae JH; Kim G Nutr Res; 2018 Feb; 50():1-9. PubMed ID: 29540267 [TBL] [Abstract][Full Text] [Related]
33. Dietary supplement drug therapies for depression. Howland RH J Psychosoc Nurs Ment Health Serv; 2012 Jun; 50(6):13-6. PubMed ID: 22589230 [TBL] [Abstract][Full Text] [Related]
34. Targeting Divergent Pathways in the Nutritional Management of Depression. Tobin D; Vuckovic A; Sarris J Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203943 [TBL] [Abstract][Full Text] [Related]
35. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial. Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463 [TBL] [Abstract][Full Text] [Related]
36. Nutraceutical Augmentation Strategies for Depression: A Narrative Review. Lande RG J Am Osteopath Assoc; 2020 Feb; 120(2):100-106. PubMed ID: 31985760 [TBL] [Abstract][Full Text] [Related]
37. Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: a randomized controlled pilot study. Bot M; Pouwer F; Assies J; Jansen EH; Beekman AT; de Jonge P Neuropsychobiology; 2011; 63(4):219-23. PubMed ID: 21422768 [TBL] [Abstract][Full Text] [Related]
38. Omega 3 polyunsaturated fatty acids and the treatment of depression. Deacon G; Kettle C; Hayes D; Dennis C; Tucci J Crit Rev Food Sci Nutr; 2017 Jan; 57(1):212-223. PubMed ID: 25830700 [TBL] [Abstract][Full Text] [Related]
39. Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence. Hoepner CT; McIntyre RS; Papakostas GI Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652997 [TBL] [Abstract][Full Text] [Related]
40. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]